David Hugh Williams
Founder at Nanna Therapeutics Ltd.
Profile
David Hugh Williams is the founder of Sareum Holdings Plc (founded in 2003), Discuva Ltd., and Nanna Therapeutics Ltd.
(founded in 2012).
At Sareum Holdings Plc, he was a Non-Executive Director in 2008.
At Discuva Ltd., he was the Chief Executive Officer & Director.
At Nanna Therapeutics Ltd., he is currently the Managing Director & Director.
Mr. Williams's former jobs include Director-Structural Biology at Millennium Pharmaceuticals, Inc., Associate Director-Biomolecular Sciences at Medivir AB, Research Scientist at F.
Hoffmann-La Roche Ltd., and Head-Molecular Immunology at Acambis Plc.
David Hugh Williams active positions
| Companies | Position | Start |
|---|---|---|
Nanna Therapeutics Ltd.
 Nanna Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nanna Therapeutics Ltd. engages in development of pharmaceutical products. It provides drugs for combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. The company is headquartered in Cambridge, the United Kingdom. | Founder | 2011-12-31 |
Former positions of David Hugh Williams
| Companies | Position | End |
|---|---|---|
| SAREUM HOLDINGS PLC | Founder | 2008-08-28 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - |
| MEDIVIR AB | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| MEDIVIR AB | Health Technology |
| Private companies | 5 |
|---|---|
Nanna Therapeutics Ltd.
Nanna Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nanna Therapeutics Ltd. engages in development of pharmaceutical products. It provides drugs for combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
Discuva Ltd.
 Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- David Hugh Williams
